Danaher Corp (DHR)

$175.15 -3.80 (-2.12%)
Market Cap 123.97B
Revenue (ttm) 24.57B
Net Income (ttm) 3.61B
EPS (ttm) N/A
PE Ratio 22.42
Forward PE 21.22
Profit Margin 14.71%
Debt to Equity Ratio 0.33
Volume 3,880,100
Avg Vol 4,257,512
Day's Range N/A - N/A
Shares Out 707.77M
Stochastic %K 2%
Beta 0.81
Analysts Strong Sell
Price Target $245.70

Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell cultu...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 202 828 0850
Fax: 202 828 0860
Address:
2200 Pennsylvania Avenue N.W., Suite 800W, Washington, United States
kimbroughbc
kimbroughbc May. 4 at 4:26 AM
$DHR I believe we are at the bottom here. A turn around will happen soon.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER May. 1 at 8:00 PM
$BSX once again the $IHI says it all for the medical device companies $BSX $MDT $DHR ... move back to that hind tit again... maybe further
0 · Reply
pilobious
pilobious May. 1 at 5:27 PM
$DHR all health care is being trashed. 25 million losing health insurance this year. Less business. SYK, ABT, BSX. Fewer devices will be sold.
2 · Reply
Popo_Jijo
Popo_Jijo May. 1 at 3:35 PM
$DHR new 52 week low today. can someone please remind me, or more importantly please remind rainer, what the s&p is doing?
1 · Reply
Mergerbrief
Mergerbrief May. 1 at 11:55 AM
$MASI / $DHR – Shareholder Vote $MASI
0 · Reply
CapitalMonk
CapitalMonk May. 1 at 1:45 AM
$DHR Price: $178.95 (+0.08%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.19% RSI: 36.4 | Momentum: Moderate Volume: +10.0% vs avg Volatility: 1.96% Support: $175.00 | Resistance: $200.50 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Professler
Professler May. 1 at 12:32 AM
$ABT Keep an eye on this one. A diversified health care giant trading down at 6 year support. I'll start nibbling soon since I need to diversify away from a tech heavy portfolio. I also like $DHR down here.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Apr. 30 at 4:00 PM
$BSX noticed the double bottoms on both these guys with some buying pressures building $MDT $IHI $DHR $BDX
0 · Reply
green_going_up
green_going_up Apr. 23 at 10:43 PM
$TMO $DHR the question is really whether AI will create LESS need for their products and a lower # of clinical trial work - if you can run the analytics to eliminate certain molecules or combinations of molecules that have no chance in working - or MORE need for their products - if the AI provides a greater number of molecules or combinations of molecules to test in humans. If AI enables future cures of diseases, then surely, there will be less aggregate demand for testing equipment over time.
2 · Reply
DosGatos
DosGatos Apr. 23 at 9:47 PM
$DHR Vrabel wifey bout to get PAID!
0 · Reply
Latest News on DHR
Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Apr 23, 2026, 1:39 PM EDT - 10 days ago

Danaher reaches $172.5 million settlement with shareholders over post-pandemic outlook

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Apr 22, 2026, 7:15 PM EDT - 11 days ago

Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

Apr 21, 2026, 12:00 PM EDT - 12 days ago

Danaher Q1 Earnings Beat Estimates, But Revenue Miss, Weak Diagnostics Weigh On Stock

Danaher Earnings Call Transcript: Q1 2026

Apr 21, 2026, 8:00 AM EDT - 12 days ago

Danaher Earnings Call Transcript: Q1 2026

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Apr 21, 2026, 7:33 AM EDT - 12 days ago

Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Danaher beats first-quarter profit estimates on strong bioprocessing demand

Apr 21, 2026, 7:28 AM EDT - 12 days ago

Danaher beats first-quarter profit estimates on strong bioprocessing demand

Danaher Reports First Quarter 2026 Results

Apr 21, 2026, 6:00 AM EDT - 12 days ago

Danaher Reports First Quarter 2026 Results

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

Apr 13, 2026, 3:01 AM EDT - 20 days ago

Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Apr 9, 2026, 6:50 PM EDT - 24 days ago

Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Danaher Schedules First Quarter 2026 Earnings Conference Call

Mar 20, 2026, 4:15 PM EDT - 6 weeks ago

Danaher Schedules First Quarter 2026 Earnings Conference Call

Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Mar 3, 2026, 1:50 PM EST - 2 months ago

Danaher Transcript: TD Cowen 46th Annual Health Care Conference

Danaher Announces Quarterly Dividend

Feb 24, 2026, 4:30 PM EST - 2 months ago

Danaher Announces Quarterly Dividend

Danaher to Present at TD Cowen Health Care Conference

Feb 24, 2026, 4:05 PM EST - 2 months ago

Danaher to Present at TD Cowen Health Care Conference

Danaher to buy Masimo for $9.9 billion

Feb 17, 2026, 8:04 AM EST - 2 months ago

Danaher to buy Masimo for $9.9 billion

MASI

Masimo to be Acquired by Danaher for $180.00 Per Share

Feb 17, 2026, 8:02 AM EST - 2 months ago

Masimo to be Acquired by Danaher for $180.00 Per Share

MASI

Danaher To Acquire Masimo Corporation

Feb 17, 2026, 8:00 AM EST - 2 months ago

Danaher To Acquire Masimo Corporation

MASI

Danaher Strikes $10 Billion Deal for Masimo

Feb 17, 2026, 6:09 AM EST - 2 months ago

Danaher Strikes $10 Billion Deal for Masimo

MASI

Danaher closes in on nearly $10 billion deal for Masimo, FT reports

Feb 16, 2026, 11:11 PM EST - 2 months ago

Danaher closes in on nearly $10 billion deal for Masimo, FT reports

MASI

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Feb 12, 2026, 12:30 PM EST - 2 months ago

Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights

Danaher Expects Gradual Improvement In End-Market Conditions

Jan 28, 2026, 9:46 AM EST - 3 months ago

Danaher Expects Gradual Improvement In End-Market Conditions

Danaher Earnings Call Transcript: Q4 2025

Jan 28, 2026, 8:00 AM EST - 3 months ago

Danaher Earnings Call Transcript: Q4 2025

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Jan 28, 2026, 7:08 AM EST - 3 months ago

Danaher forecasts 2026 profit in line with estimates on pharma spending recovery

Danaher Reports Fourth Quarter and Full Year 2025 Results

Jan 28, 2026, 6:00 AM EST - 3 months ago

Danaher Reports Fourth Quarter and Full Year 2025 Results

Danaher Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 13, 2026, 2:15 PM EST - 3 months ago

Danaher Transcript: 44th Annual J.P. Morgan Healthcare Conference

Danaher CEO to Comment on Financial Performance

Jan 12, 2026, 9:00 AM EST - 3 months ago

Danaher CEO to Comment on Financial Performance

The Big 3: BA, DHR, DG

Jan 8, 2026, 1:05 PM EST - 4 months ago

The Big 3: BA, DHR, DG

BA DG

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Jan 8, 2026, 8:00 AM EST - 4 months ago

Danaher Is Ready to Put Its Post-Covid Malaise Behind It

Danaher to Present at J.P. Morgan Healthcare Conference

Jan 5, 2026, 4:15 PM EST - 4 months ago

Danaher to Present at J.P. Morgan Healthcare Conference

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 24, 2025, 11:48 AM EST - 4 months ago

HALPER SADEH LLC ENCOURAGES DANAHER CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

Dec 17, 2025, 7:30 AM EST - 4 months ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

Dec 4, 2025, 12:15 PM EST - 5 months ago

6 Dividend Stocks Ready To Benefit From 2026's Rate-Shift Economy

DX HSY NLY BMEZ UTG

3 More Good Stocks to Invest In After Earnings

Nov 18, 2025, 4:29 PM EST - 5 months ago

3 More Good Stocks to Invest In After Earnings

FTNT LPLA

Danaher Transcript: Jefferies London Healthcare Conference 2025

Nov 18, 2025, 6:00 AM EST - 5 months ago

Danaher Transcript: Jefferies London Healthcare Conference 2025

The Big 3: TMO, DHR, VLO

Nov 13, 2025, 12:50 PM EST - 6 months ago

The Big 3: TMO, DHR, VLO

TMO VLO

Danaher to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 4:15 PM EST - 6 months ago

Danaher to Present at Jefferies Global Healthcare Conference

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 30, 2025, 4:10 PM EDT - 6 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Oct 27, 2025, 7:53 PM EDT - 6 months ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 26, 2025, 5:50 PM EDT - 6 months ago

DHR Announcement: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Oct 22, 2025, 1:01 PM EDT - 6 months ago

These Analysts Increase Their Forecasts On Danaher Following Upbeat Q3 Earnings

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Oct 21, 2025, 10:55 AM EDT - 6 months ago

Is Danaher's Q3 beat enough to reignite long-term growth for DHR investors?

Danaher Earnings Call Transcript: Q3 2025

Oct 21, 2025, 8:00 AM EDT - 6 months ago

Danaher Earnings Call Transcript: Q3 2025

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Oct 21, 2025, 7:01 AM EDT - 6 months ago

Danaher beats quarterly estimates on strength in diagnostic tools and tech

Danaher Sales and Profit Rise on Bioprocessing Momentum

Oct 21, 2025, 6:23 AM EDT - 6 months ago

Danaher Sales and Profit Rise on Bioprocessing Momentum

Danaher Reports Third Quarter 2025 Results

Oct 21, 2025, 6:00 AM EDT - 6 months ago

Danaher Reports Third Quarter 2025 Results

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Oct 16, 2025, 10:18 PM EDT - 7 months ago

Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR

Danaher Stock: Monopoly Margins, Discounted Price

Oct 15, 2025, 10:25 AM EDT - 7 months ago

Danaher Stock: Monopoly Margins, Discounted Price

4 Stocks That Aren't Too Hot to Buy Right Now

Oct 6, 2025, 2:45 PM EDT - 7 months ago

4 Stocks That Aren't Too Hot to Buy Right Now

EVRG KNTK PWR XLU

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Sep 23, 2025, 4:15 PM EDT - 7 months ago

Danaher Schedules Third Quarter 2025 Earnings Conference Call

Analysts' Top S&P 500 Stocks to Buy Now

Sep 11, 2025, 2:26 PM EDT - 8 months ago

Analysts' Top S&P 500 Stocks to Buy Now

HWM SPGI

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

Sep 10, 2025, 8:31 AM EDT - 8 months ago

Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Sep 5, 2025, 8:39 PM EDT - 8 months ago

DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation - DHR

Danaher Stock Closes Near Day's High After Key Trading Signal

Aug 4, 2025, 7:13 AM EDT - 9 months ago

Danaher Stock Closes Near Day's High After Key Trading Signal

Danaher Appoints Jonathan Leiken as General Counsel

Jul 31, 2025, 4:15 PM EDT - 9 months ago

Danaher Appoints Jonathan Leiken as General Counsel

kimbroughbc
kimbroughbc May. 4 at 4:26 AM
$DHR I believe we are at the bottom here. A turn around will happen soon.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER May. 1 at 8:00 PM
$BSX once again the $IHI says it all for the medical device companies $BSX $MDT $DHR ... move back to that hind tit again... maybe further
0 · Reply
pilobious
pilobious May. 1 at 5:27 PM
$DHR all health care is being trashed. 25 million losing health insurance this year. Less business. SYK, ABT, BSX. Fewer devices will be sold.
2 · Reply
Popo_Jijo
Popo_Jijo May. 1 at 3:35 PM
$DHR new 52 week low today. can someone please remind me, or more importantly please remind rainer, what the s&p is doing?
1 · Reply
Mergerbrief
Mergerbrief May. 1 at 11:55 AM
$MASI / $DHR – Shareholder Vote $MASI
0 · Reply
CapitalMonk
CapitalMonk May. 1 at 1:45 AM
$DHR Price: $178.95 (+0.08%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.19% RSI: 36.4 | Momentum: Moderate Volume: +10.0% vs avg Volatility: 1.96% Support: $175.00 | Resistance: $200.50 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
Professler
Professler May. 1 at 12:32 AM
$ABT Keep an eye on this one. A diversified health care giant trading down at 6 year support. I'll start nibbling soon since I need to diversify away from a tech heavy portfolio. I also like $DHR down here.
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Apr. 30 at 4:00 PM
$BSX noticed the double bottoms on both these guys with some buying pressures building $MDT $IHI $DHR $BDX
0 · Reply
green_going_up
green_going_up Apr. 23 at 10:43 PM
$TMO $DHR the question is really whether AI will create LESS need for their products and a lower # of clinical trial work - if you can run the analytics to eliminate certain molecules or combinations of molecules that have no chance in working - or MORE need for their products - if the AI provides a greater number of molecules or combinations of molecules to test in humans. If AI enables future cures of diseases, then surely, there will be less aggregate demand for testing equipment over time.
2 · Reply
DosGatos
DosGatos Apr. 23 at 9:47 PM
$DHR Vrabel wifey bout to get PAID!
0 · Reply
DosGatos
DosGatos Apr. 23 at 9:44 PM
$DHR How you claim to be kings of continuous improvement when stock price is tanking!!
0 · Reply
profit_guru
profit_guru Apr. 23 at 6:45 PM
$DHR - way oversold …might rally tomorrow…imo
1 · Reply
profit_guru
profit_guru Apr. 23 at 2:15 PM
$DHR - might rally into close…way oversold …solid quarter and guidance…near term 200
0 · Reply
DosGatos
DosGatos Apr. 23 at 2:11 PM
$DHR GO TO GEMBA GO TO GEMBA FIX THE PROBLEM NOW!!!
2 · Reply
DosGatos
DosGatos Apr. 23 at 2:10 PM
$DHR QUICK DO A KAIZEN ON THE SHARE PRICE!!!
1 · Reply
OptionRunners
OptionRunners Apr. 23 at 1:20 PM
$DHR they exercised those puts yesterday
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 23 at 12:54 PM
$DHR (-0.8% pre) Danaher prices €3 billion euro-denominated senior notes offering https://ooc.bz/l/99803
0 · Reply
Popo_Jijo
Popo_Jijo Apr. 23 at 9:57 AM
$DHR folks talking about this stock being a great buy & hold. crazy. how’s that been working out? s&p printing fresh all-time highs while rainer is flirting with multi-year lows. look at the charts. and there is very likely more to come. wow, just wow.
1 · Reply
OptionRunners
OptionRunners Apr. 22 at 7:28 PM
$DHR Continues to sell off -5%. Again perfect example of what I was talking about. Trader added $2.6M to the position rather than de-risking it which shows conviction. They're still in the trade and up over 60% on this $6.6M position https://stocktwits.com/OptionRunners/message/649348316
0 · Reply
jewell69
jewell69 Apr. 22 at 6:54 PM
$DHR ok, ok. I lost 60 pennies here. i'm out Date Transaction Type Symbol Description Quantity Price Fees & Comm Amount 04/22/2026 Sell Edit cost basis method DHR DANAHER CORP 25 $185.56 $0.10 $4,638.90 More 04/22/2026 Buy DHR DANAHER CORP 25 $185.58 -$4,639.50 More Total $0.10 -$0.60
0 · Reply
jewell69
jewell69 Apr. 22 at 6:35 PM
$DHR Danaher Corp. AN OUTSTANDING BUY AND HOLD STOCK 04/22/2026 Buy DHR DANAHER CORP 25 $185.58 -$4,639.50 More 04/28/2023 Sell DHR TDA TRAN - Sold 20 (DHR) @234.7000 20 $234.70 $0.04 $4,693.96 More 04/26/2023 Buy DHR TDA TRAN - Bought 20 (DHR) @232.9899 20 $232.9899 -$4,659.80 More 03/03/2023 Sell DHR TDA TRAN - Sold 14 (DHR) @251.6600 14 $251.66 $0.03 $3,523.21 More 02/27/2023 Buy DHR TDA TRAN - Bought 14 (DHR) @249.1700 14 $249.17 -$3,488.38
1 · Reply
jewell69
jewell69 Apr. 22 at 6:34 PM
185.58 limit buy price 2:32 pm edt on $DHR for 25 shares now b a .55 x .65
0 · Reply